男性乳腺癌保乳手术与全乳切除术的比较
本研究基于TriNetX网络回顾性分析男性乳腺癌患者,比较保乳手术与全乳切除术的结局。倾向性评分匹配后每组401例,两组5年总生存率和局部复发率无差异,但全乳切除术组术后并发症风险更高。结论认为对于单中心性T1和T2男性乳腺癌,保乳手术可行且优先推荐。
要点
- 男性乳腺癌保乳手术与全乳切除术的5年总生存率和局部复发率无显著差异。
- 全乳切除术组术后并发症风险(24%)高于保乳手术组(17%)。
- 对于单中心性T1和T2男性乳腺癌,保乳手术可行且应优先考虑。
核心结论
- 男性乳腺癌患者接受保乳手术或全乳切除术的5年总生存率和局部复发率无差异。
- 全乳切除术的术后并发症发生率高于保乳手术。
- 对于单中心性男性乳腺癌,保乳手术是可行且优先推荐的选择,尤其适用于T1和T2肿瘤。
研究设计与样本
- 回顾性队列研究,使用TriNetX网络检索18岁及以上确诊乳腺癌的男性患者。
- 队列1为接受保乳手术的患者,队列2为接受全乳切除术的患者。
- 采用倾向性评分匹配,匹配变量包括年龄、BMI、吸烟、癌症分期和肿瘤大小(T1至T4)、放疗、化疗、激素治疗、遗传学和合并症。
- 匹配后每组各401例患者。
- 主要结局为5年总生存率、局部复发和术后并发症。
主要发现
- 匹配前保乳手术组423例,全乳切除术组1101例。
- 匹配后5年总生存率:保乳手术组84% vs 全乳切除术组86%,log-rank检验p=0.412。
- 局部复发率:保乳手术组11% vs 全乳切除术组13%,p=0.384。
- 术后并发症风险:全乳切除术组24% vs 保乳手术组17%,p=0.011。
临床怎么用
- 对于单中心性T1和T2男性乳腺癌,可考虑保乳手术作为首选术式。
- 保乳手术与全乳切除术的肿瘤学结局相似,但并发症更少,可用于医患共同决策。
局限性
- 本研究为回顾性研究,存在选择偏倚和未测量混杂因素的可能。
- 研究基于TriNetX网络数据,结果外推需谨慎。
- 原文未报告保乳手术的具体禁忌证或放疗方案细节。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Male breast cancer (MBC) is a rare disease, accounting for 1% of all breast cancer diagnosed in the US. The rarity of MBC has limited the development of treatment algorithms specific to men. Therefore, the standard of care has been mastectomy. The safety and feasibility of breast-conserving surgery (BCS) in MBC are unclear. This study assessed whether overall survival (OS) outcomes, local recurrence (LR), and postoperative complications differed between patients with MBC who underwent conservative surgery or mastectomy. STUDY DESIGN: A retrospective search for men aged 18 years or older diagnosed with breast cancer was conducted using the TriNetX network. Cohort 1 included patients who underwent BCS. Cohort 2 included patients who underwent mastectomy. Propensity score matching was conducted using age, BMI, tobacco use, cancer stage and tumor size (T1 to T4), radiation, chemotherapy, hormonal therapy, genetics, and comorbidities. Outcomes of interest were 5-year OS, LR, and postoperative complications. RESULTS: A total of 423 patients underwent BCS, and 1,101 patients underwent mastectomy. After matching, 401 patients per cohort were identified. No difference was observed in 5-year OS with the Kaplan-Meier analysis (Cohort 1: 84% vs Cohort 2: 86%, log-rank test p = 0.412) or with LR (11% vs 13%, p = 0.384). The mastectomy cohort was more likely to have postoperative complications, with a risk of 24% compared with 17% in the BCS cohort (p = 0.011). CONCLUSIONS: No difference was observed in the 5-year OS and LR rate between patients with MBC who undergo BCS or mastectomy. The postoperative complication rate was higher with mastectomies. We conclude that BCS for unicentric MBC is feasible and preferred for T1 and T2 cancers.
引用
- Den J, Nelson N, Khanipov K, et al. Breast Conservation Surgery for Breast Cancer in Men. J Am Coll Surg. 2025. PMID: 39807785. doi:10.1097/XCS.0000000000001285
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。